Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Lastly, tofogliflozin treatment was associated with reduction of liver steatosis, as measured by MRI-PDFF, in a Japanese randomized open-label trial (ToPiND study) that compared it with pioglitazone treatment in diabetics
PlexusDx's precision-wellness approach helps you evaluate these factors alongside clinical evidence to support a more informed conversation with your healthcare provider
The 2023 American Diabetes Association Standards of Care emphasize that GLP-1 receptor agonists are first-line agents for type 2 diabetes management and cardiovascular risk reduction
Consent for publication There were no human study participants in this review
US$ 26.56
US$ 26.11
US$ 27.19
US$ 29.30
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 26.93
US$ 27.37
US$ 23.09
US$ 20.36
US$ 28.82
US$ 25.19
US$ 28.68
